RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Differences in perceptions of community stigma towards opioid use disorder between community substance use coalition members and the general public
Walker, D. M., Lefebvre, R. C., Davis, A., Shiu-Yee, K., Chen, S., Jackson, R. D., Helme, D., Oga, E., Oser, C., Stotz, C., Balvanz, P., Asman, K., Holloway, J. L., Lewis, N., & Knudsen, H. K. (2024). Differences in perceptions of community stigma towards opioid use disorder between community substance use coalition members and the general public. Journal of substance use and addiction treatment, 158, Article 209276. https://doi.org/10.1016/j.josat.2023.209276
INTRODUCTION: To examine differences in perceptions about community stigma towards individuals with opioid use disorder (OUD) between community members involved in the opioid response (i.e., coalition members) and the general public, and how community geography may moderate this relationship.
METHODS: This study administered identical cross-sectional surveys about perceived community opioid-related stigma to two distinct populations in 66 communities participating in the HEALing Communities Study prior to the intervention period (i.e., coalition members, November 2019-January 2020; residents, March-April 2020). Linear-mixed models compared survey responses of populations, including the moderating effect of community rural/urban location.
RESULTS: A total of 826 coalition members and 1131 residents completed the surveys. The study found no differences between the coalition members and residents for general perceived community opioid-related stigma. In both urban and rural communities, coalition members reported greater perceived community stigma than residents reported towards medication for opioid use disorder (MOUD), naloxone, and drug treatment as an alternative to incarceration.
CONCLUSION: Our findings suggest similar perceived community opioid-related stigma between coalition members and residents, yet differences emerge related to evidence-based practices (i.e., MOUD, naloxone, and drug treatment as an alternative to incarceration) to reduce opioid overdose deaths.
